Sana Biotechnology, Inc.
SANA
$3.55
-$0.12-3.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 32.16% | 4.41% | -19.88% | 29.66% | -86.51% |
| Total Depreciation and Amortization | -21.81% | -34.48% | -19.70% | -21.35% | -26.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -55.09% | 75.65% | 419.82% | 101.16% | 522.31% |
| Change in Net Operating Assets | 133.32% | 40.06% | -20.07% | 302.62% | -243.34% |
| Cash from Operations | 0.94% | 23.18% | 30.79% | 43.21% | 43.46% |
| Capital Expenditure | -1,547.32% | -111.76% | -100.23% | 99.00% | 100.86% |
| Sale of Property, Plant, and Equipment | -93.98% | -1.98% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,295.67% | 200.12% | -134.26% | -204.91% | -61.93% |
| Cash from Investing | -1,239.57% | 197.76% | -135.03% | -214.96% | 32.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.14% | -7.06% | -- | -- | -- |
| Issuance of Common Stock | 15,841.91% | -94.76% | 2,437.77% | 5,639.63% | -80.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 60.00% | -60.00% | -- | -- | -- |
| Cash from Financing | 16,581.28% | -113.03% | 2,644.95% | 5,161.29% | -94.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.51% | 138.39% | -5,624.04% | 502.99% | 40.94% |